In the current study, we determined whether HDL CEC and LCAT activity are altered in a large APOE genotyped cohort of elderly participants clinically diagnosed as either non-demented, MCI, or Alzheimer’s disease dementia (AD). The gene discussed is LCAT; the disease is Alzheimer disease.